INS and Hyperglycemia: These are, at least in part, attributed to the fact that increasing circulating MG53 causes whole body insulin resistance.22 Injection of rhMG53-WT induced significant elevation in blood glucose on top of hyperglycemia in db/db mice, which was more severe and harmful in mice with advanced diabetes whose insulin sensitivity and glucose handling ability were deteriorated.